NYU-Langone Medical Center — New York, New York

NYU-Langone Medical Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

NYU-Langone Medical Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis, Advanced Solid Tumors.

Sponsors: Hoffmann-La Roche, InnoCare Pharma Inc..

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU-Langone Medical Center?

NYU-Langone Medical Center has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU-Langone Medical Center conducted?

NYU-Langone Medical Center has 2 clinical trials on record, with 1 currently active. Their work covers NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis, Advanced Solid Tumors.

Is NYU-Langone Medical Center accredited by Crixeo Health?

NYU-Langone Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU-Langone Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.